Charles Explorer logo
🇬🇧

Inhibitory DPP-4-gliptins: clinical practice 2010

Publication at Second Faculty of Medicine |
2011

Abstract

DPP-4-gliptin inhibitors are a new class of drugs for intervention in patients with type 2 diabetes. Gliptins are an effective, safe and effective therapy.

The advantages are a low risk of hypoglycemia and a neutral effect on body weight.

Keywords